Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Hot Flashes|Breast Neoplasms
Interventions: DRUG: Desvenlafaxine succinate 100mg|DRUG: Desvenlafaxine succinate 50mg|DRUG: Placebo
Sponsor: Seoul National University Hospital
Collaborators: Seoul National University Bundang Hospital|Korea Cancer Center Hospital|Pfizer